Viz.ai Expands AI Platform with Pulmonary Care Suite

Event summary

  • Viz.ai launched the Viz Pulmonary Suite, an AI-powered solution for pulmonary care delivery, on May 14, 2026.
  • The suite integrates acute and chronic pulmonary workflows, aiming to reduce health system leakage and improve patient outcomes.
  • Early findings show Viz PE reduced time to treatment from 1.75 days to 0.56 days and lowered in-hospital mortality among high-risk PE patients.
  • The suite will be showcased at the American Thoracic Society Annual Conference from May 17-19, 2026.

The big picture

Viz.ai’s launch of the Viz Pulmonary Suite underscores the growing trend of AI-driven care coordination in healthcare. The suite addresses critical gaps in pulmonary care, where fragmented workflows often lead to missed diagnoses and treatment delays. With the Viz Platform already deployed in 2,000 hospitals across the U.S., this expansion positions Viz.ai to further solidify its leadership in AI-powered disease detection and care coordination.

What we're watching

Adoption Pace
How quickly health systems integrate the Viz Pulmonary Suite into existing EHR systems and workflows.
Outcome Validation
Whether early promising results from single-center studies can be replicated at scale across Viz.ai’s network.
Market Expansion
The pace at which Viz.ai can expand the suite’s capabilities to cover additional pulmonary conditions beyond COPD, lung nodules, and pulmonary embolism.

Related topics

Product Launch